Dr.Jothydev Kesavadev enunciated on “Bringing GLP1 early in the conversations” in a national webinar- DECON 2020, organized by Dr.Suresh Damodaran. It’s increasingly recommended to use GLP1RA such as Liraglutide early in type 2 diabetes to prevent future vascular complications. Though there is incremental cost difference in the beginning, this results in huge cost savings in the future and in addition prevention of devastating complications. The session was moderated by Dr.Sabeer. A. Rasheed. The webinar received active participation from physicians across the country.